Secteur Karyopharm Therapeutics Inc. BOERSE MUENCHEN
Actions
25K0
US48576U2050
Produits pharmaceutiques
|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 8,400 EUR | +6,33% |
|
+7,01% | - |
| 02/06 | Transcript : Karyopharm Therapeutics Inc. - Special Call | |
| 02/06 | Karyopharm s'apprête à publier les données de phase 3 sur l'association sélinexor et ruxolitinib dans la myélofibrose | MT |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0,90% | +0,54% | -3,26% | -16,09% | -19,93% | +20,73% | -20,74% | +16,65% | +73,05% | 62,32 Md | ||
| +1,66% | +0,68% | +4,01% | +1,25% | +5,49% | +53,10% | +200,79% | +204,21% | +285,57% | 53,94 Md | ||
| -1,70% | +27,30% | +27,30% | +27,30% | +27,30% | +27,30% | +27,30% | +27,30% | - | 38,98 Md | ||
| +4,28% | +9,30% | +18,53% | -16,26% | -32,40% | -51,61% | -58,31% | -59,28% | +9,34% | 37,89 Md | ||
| -1,26% | +0,81% | +1,77% | +7,38% | +12,05% | +58,06% | -30,69% | -46,98% | -17,36% | 29,48 Md | ||
| +2,79% | +10,11% | +30,12% | +18,95% | +106,85% | +137,63% | -48,52% | -71,23% | - | 23,55 Md | ||
| +0,71% | +4,66% | +7,45% | +15,42% | +5,70% | +55,22% | +67,17% | +22,64% | +27,85% | 20,71 Md | ||
| +2,75% | +5,01% | -1,57% | -3,62% | +3,08% | -4,26% | +153,55% | -14,29% | - | 16,71 Md | ||
| +4,86% | +8,36% | +5,66% | +29,56% | +40,14% | +68,50% | +121,25% | +215,14% | +347,60% | 16,02 Md | ||
| -0,42% | +2,99% | -0,71% | -1,39% | -10,28% | +62,73% | +338,25% | +15,64% | - | 13,5 Md | ||
| -2,37% | -3,95% | +2,54% | +54,28% | +32,48% | +138,04% | +174,62% | +247,26% | +3 167,66% | 12,75 Md | ||
| -4,99% | -5,53% | -8,64% | +0,76% | -25,92% | -12,37% | +688,17% | +410,34% | +6 024,14% | 12,21 Md | ||
| +1,07% | +2,50% | +4,46% | +3,14% | -4,93% | +4,47% | -39,57% | -31,58% | -32,46% | 10,8 Md | ||
| -0,94% | +5,21% | +13,61% | +36,04% | +37,99% | +146,67% | +184,69% | +414,46% | - | 10,12 Md | ||
| -0,86% | -1,13% | -5,49% | +1,59% | -16,37% | -11,67% | -21,95% | -59,80% | -54,35% | 6,28 Md | ||
| +9,70% | +18,85% | +6,12% | +0,04% | +10,09% | +19,07% | +294,84% | +204,90% | - | 5,46 Md | ||
| -0,45% | -1,35% | -22,21% | -27,75% | -36,56% | -54,60% | -57,19% | -77,61% | - | 5,35 Md | ||
| -0,20% | +0,06% | +40,33% | +91,01% | +167,97% | +140,59% | +391,90% | -29,25% | - | 5,3 Md | ||
| +1,95% | +4,30% | -8,27% | -25,16% | -30,73% | -26,05% | +120,39% | +37,75% | +119,53% | 5,13 Md | ||
| Moyenne | +0,91% | +1,73% | +5,88% | +10,34% | +14,32% | +40,61% | +130,84% | +75,07% | +904,60% | 20,34 Md | |
| Moyenne pondérée par Capi. | +0,94% | +1,19% | +7,54% | +5,71% | +8,68% | +38,10% | +84,71% | +62,30% | +522,55% |
- Bourse
- Actions
- Action KPTI
- Action 25K0
- Secteur Karyopharm Therapeutics Inc.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
















